Andrews Julie 4
4 · Orthofix Medical Inc. · Filed Mar 6, 2026
Research Summary
AI-generated summary of this filing
Orthofix (OFIX) CFO Julie Andrews Sells Shares
What Happened Julie Andrews, Chief Financial Officer of Orthofix Medical Inc. (OFIX), sold a total of 4,788 shares in two open-market sell transactions to satisfy tax withholding obligations related to the settlement of restricted stock units. On 2026-03-04 she sold 2,425 shares at a weighted-average price of $12.92 for proceeds of $31,322, and on 2026-03-05 she sold 2,363 shares at a weighted-average price of $12.55 for proceeds of $29,658 — about $60,980 total. These sales were made under a pre-existing sell-to-cover requirement and were executed without the reporting person's discretion.
Key Details
- Transaction dates and prices:
- 2026-03-04: 2,425 shares sold, weighted-average price $12.92 (individual prices ranged $12.80–$13.03; see footnote F2).
- 2026-03-05: 2,363 shares sold, weighted-average price $12.55 (individual prices ranged $12.48–$12.72; see footnote F4).
- Total shares sold: 4,788; total proceeds ≈ $60,980.
- Reason: Sell-to-cover to satisfy tax withholding on vested restricted stock units (footnote F1). Sale executed pursuant to a pre-existing plan and without the reporting person's discretion.
- Holdings note: Footnote F3 references 69,552 previously reported restricted stock units included in the reporting person's holdings.
- Filing timeliness: Form 4 filed 2026-03-06 for transactions on 2026-03-04 and 2026-03-05 — appears timely (filed within the required window).
Context
- These were routine sell-to-cover transactions to meet tax obligations tied to RSU settlement, not open-market discretionary sales. Such tax-withholding sales are common after RSU vesting and generally should not be interpreted on their own as a directional insider signal.
Insider Transaction Report
Form 4
Transactions
- Sale
Common Stock
[F1][F2][F3]2026-03-04$12.92/sh−2,425$31,322→ 91,109 total - Sale
Common Stock
[F1][F4][F3]2026-03-05$12.55/sh−2,363$29,658→ 88,746 total
Footnotes (4)
- [F1]Represents the number of shares of common stock sold to satisfy tax withholding obligations in connection with the settlement of restricted stock units, pursuant to a pre-existing sell-to-cover requirement previously approved and mandated by the Compensation and Talent Development Committee of the Company's Board of Directors (the administrator of the plan pursuant to which such restricted stock units were granted). Such sale was made without the exercise of any discretion by the reporting person.
- [F2]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $12.80 to $13.03, inclusive. The reporting person undertakes to provide to Orthofix Medical Inc., any security holder of Orthofix Medical Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (2) and (4) to this Form 4.
- [F3]Includes 69,552 previously reported restricted stock units.
- [F4]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $12.48 to $12.72, inclusive.
Signature
/s/ J. Andres Cedron, Attorney-in-fact|2026-03-06